Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease

Neurology

Volumn 63, Issue 8, 2004, Pages 1376-1384

  Cairns, Nigel J ^a,k   Grossman, M ^a   Arnold, S E ^a   Burn, D J ^d   Jaros, E ^d   Perry, R H ^d   Duyckaerts, C ^f   Stankoff, B ^f   Pillon, B ^f   Skullerud, K ^g   Cruz Sanchez, F F ^h   Bigio, E H ^b   Mackenzie, I R A ⁱ   Gearing, M ^c   Juncos, J L ^c   Glass, J D ^c   Yokoo, H ^j   Nakazato, Y ^j   Mosaheb, S ^e   Thorpe, J R ^e   Uryu, K ^a   Lee, V M Y ^a   Trojanowski, J Q ^a   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SUSSEX   (United Kingdom)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

ⁱ VANCOUVER GENERAL HOSPITAL   (Canada)

^j GUNMA UNIVERSITY   (Japan)

^k WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERNEXIN; NEUROFILAMENT TRIPLET PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AMNESIA; APRAXIA; ARTICLE; BEHAVIOR DISORDER; BRAIN ATROPHY; BUCCOFACIAL APRAXIA; CAUDATE ATROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; DYSTONIA; EXECUTIVE DYSFUNCTION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FRONTOTEMPORAL ATROPHY; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; HYPERREFLEXIA; INTERMEDIATE FILAMENT; LANGUAGE DISABILITY; LIMB DYSTONIA; MALE; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEURONAL INTERMEDIATE FILAMENT INCLUSION DISEASE; NEUROPATHOLOGY; ONSET AGE; OPHTHALMOPLEGIA; PARKINSONISM; PERSEVERATION; PERSONALITY DISORDER; PRIORITY JOURNAL; REFLEX; RETROSPECTIVE STUDY; SUPRANUCLEAR OPHTHALMOPLEGIA; TAUOPATHY; UPPER MOTOR NEURON DISEASE;

EID: 7044262166     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000139809.16817.DD     Document Type: Article

References (37)

1. Cairns NJ, Perry RH, Jaros E, et al. Patients with a novel neurofilamantopathy: dementia with neurofilament inclusions. Neurosci Lett 2003;341:177-180.
2. Cairns NJ, Zhukareva V, Uryu K, et al. α-Internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol 2004;164:2153-2161.
3. Cairns NJ, Uryu K, Bigio E, et al. α-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neruodegenerative diseases. Acta Neuropathol 2004;108;213-233.
4. Bigio EH, Lipton AM, White III CL, et al. Frontotemporal dementia and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 2003;29:239-253.
5. Duyckaerts C, Mokhtari K, Fontaine B, et al. Maladie de Pick généralisée: une démence mal nommée caractérisée par des inclusions neurofilamentaires. Rev Neurol (Paris) 2003;159:219-219.
6. Gearing M, Castellano AA, Hunter SB, et al. Unusual neuropathologic findings in a case of primary lateral sclerosis. J Neuropathol Exp Neurol 2003;62:555-555.
7. Yokoo H, Oyama T, Hirato J, et al. A case of Pick's disease with unusual neuronal inclusions. Acta Neuropathol 1994;88:267-272.
8. Josephs KA, Holton JL, Rossor MN, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003;126:2291-2303.
9. Lee K, Cleveland DW. Neuronal intermediate filaments. Ann Rev Neurosci 1996;19:187-217.
10. Garden MJ, Trojanowski JQ, Schlaepfer WW, et al. Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns. J Neurosci 1987;7:3499-3504.
11. Lee VM-Y, Garden MJ, Schlaepfer WW, et al. Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats. J Neurosci 1987;7:3478-3488.
12. Schmidt ML, Garden MJ, Lee VM-Y, et al. Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. Lab Invest 1987;56:282-294.
13. Schmidt ML, Lee VM-Y, Trojanowski JQ. Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles. Am J Pathol 1990;136:1069-1075.
14. Schmidt ML, Lee VM-Y, Trojanowski JQ. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads. Lab Invest 1991;64:352-357.
15. Schmidt ML, Murray J, Lee VM-Y, et al. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 1991;139:53-65.
16. Goldstein E, Sternberger NM, Sternberger LA. Phosphorylation protects neurofilaments against proteolysis. J Neuroimmunol 1987;14:149-160.
17. Al-Chalabi A, Miller CCJ. Neurofilaments and neurological disease. BioEssays 2003;25:346-365.
18. Galvin JE, Nakamura M, McIntosh TK, et al. Neurofilament-rich intraneuronal inclusions exacerbate neurodegenerative sequalae of brain trauma in NFH/LacZ transgenic mice. Exp Neurol 2000;165:77-89.
19. Ching GY, Liem RKH. Structure of the gene for the neuronal intermediate filament protein α-internexin and functional analysis of its promoter. J Biol Chem 1991;29:19459-19468.
20. Fliegner KH, Kaplan MP, Wood TL, et al. Expression of the gene for the neuronal intermediate filament protein α-internexin coincides with the onset of neuronal differentiation in the developing rat nervous system. J Comp Neurol 1994;342:161-173.
21. Ching GY, Liem RKH. Roles of head and tail domains in α-internexin's self-assembly and coassembly with the neurofilament triplet proteins. J Cell Science 1998;111:321-333.
22. Ching GY, Chien C-L, Flores R, et al. Overexpression of α-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice. J Neurosci 1999;19:2974-2986.
23. Lee VM-Y, Otvos L Jr., Schmidt ML, et al. Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteins. Proc Natl Acad Sci USA 1988;85:7384-7388.
24. Duda JE, Giasson BI, Mabon ME, et al. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 2002;52:205-210.
25. Thorpe JR, Morley SJ, Rulten SL. Utilizing the peptidyl-prolyl cis-trans isomerase pin1 as a probe of its phosphorylated target proteins. Examples of binding to nuclear proteins in a human kidney cell line and to tau in Alzheimer's diseased brain. J Histochem Cytochem 2001;49:97-108.
26. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
27. Neary D, Snowden JS, Mann DMA, et al. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiat 1990;53:23-32.
28. Boeve BF, Lang AE, Lang AE. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Neurology 2003;54(suppl):S15-S19.
29. Brooks BR. El Escorial World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sci 1994;124(suppl):96-107.
30. Kertesz A, Kawarai T, Rogaeva E, et al. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 2000;54:818-827.
31. Leigh PN, Dodson A, Swash M, et al. Cytoskeletal abnormalities in motor neuron disease: an immunohistochemical study. Brain 1989;112:521-535.
32. Okamoto K, Hirai S, Yamazaki T, et al. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 1991;129:233-236.
33. Manetto V, Sternberger NH, Perry G, et al. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1988;47:642-653.
34. Strong MJ, Strong WL, Jaffe H, et al. Phosphorylation state of the native high-molecular-weight neurofilament subunit protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis. J Neurochem 2001;76:1315-1325.
35. Ikemoto A, Hirano A, Akiguchi I. Neuropathology of amyotrophic lateral sclerosis with extra-motor system degeneration: characteristics and differences in the molecular pathology between ALS with dementia and Gumanian ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:97-104.
36. Durham HD. Aggregation of intermediate filaments by 2,5-hexanedione: comparison of effects on neurofilaments, GFAP filaments and vimentin filaments in dissociated cultures of mouse spinal cord dorsal root ganglia. J Neuropathol Exp Neurol 1988;47:432-442.
37. Mackenzie IRA, Feldman H. Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis. Clin Neuropathol 2004;23:183-193.